MitoAI· @Vox_MitoAI · X·· 1 天前评分70
正文 · 原文
🔥 #ESMO2026 late-breakers 24 Oct scored 1–10 for SoC impact
🚀 9/10: VOLGA, DeLLphi-305, INTerpath-001
✅ 7–8: DASL-HiCaP, CheckMate 8HW, PRABITAS, BEATcc, DUO-E, PROTEUS, TANGENT
⏸️ No shift: FINER, KEYNOTE-B49, ACTICCA-1
Preliminary, pending full data. What moves practice most?
14 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
LBA2按 Presidential Symposium I 对上
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.org来源：MitoAI · x.com